Antibiyotiklerin Sınıflandırılması ve Etki Mekanizmaları

Yazarlar

Özet

Antimikrobiyal kemoterapi, 1920'lerde penisilinin keşfinden bu yana insanlarda bulaşıcı hastalıklarının tedavisinde hayati bir rol oynamıştır (1). Yüzlerce antimikrobiyal ajan geliştirilmiştir ve çeşitli sınıflardaki birden fazla ajan şu anda klinik kullanım için mevcuttur (1). Ancak, ajanların çokluğu ve sürekli geliştirilmesi, klinisyenlerin alandaki ilerlemeyi takip etmesini zorlaştırdığı gibi  rutin ve özel duyarlılık testlerine hangi ajanların dahil edilmesinin uygun olduğuna karar vermesi gereken klinik mikrobiyologlar için de önemli zorluklar ortaya koymaktadır (1).  Antibakteriyel ajanları sınıflandırmanın üç yolu vardır:
Bakterisidal veya bakteriyostatik olmalarına göre
Hedef bölgeye göre
Kimyasal yapıya göre

Referanslar

Lewis JS, Bush K. Antibacterial Agents In. James H. Jorgensen JH, Pfaller MA (eds) Manual of Clinical Microbiology 11th ed. Washington, DC:ASM Press.;2015. p. 1171-1211.

Goering R. Attacking the enemy: antimicrobial agents and chemotherapy. In Goering R, Zuckerman M, Dockrell HM, Chiodini PL (eds) Mims’Medical Microbiologyand Immunology, 7th ed. Edinburgh: Elsevier Inc.;2025. p. 495-539.

Murray PR, Rosenthal KS, Pfaller MA. Antibacterial Agents. In: Murray PR Rosenthal KS, Pfaller MA (eds) Medical Microbiology. 9th ed. Edinburgh: Elsevier Inc.; 2021. p. 169-177.

Doi Y. Penicillins In: Bennett JE, Dolin R, Blaser MJ (eds) Mandell, Douglas, and Bennett's Principles and Practice of Infectious Disease. 9th ed. Philadelphia: Elsevier Inc.; 2020. p. 251-267.

Lepak AJ, Andes DR. Cephalosporins In: Bennett JE, Dolin R, Blaser MJ (eds) Mandell, Douglas, and Bennett's Principles and Practice of Infectious Disease. 9th ed. Philadelphia: Elsevier Inc.; 2020. p. 268-284.

Doi Y. Ertapenem, Imipenem, Meropenem, Doripenem, and Aztreonam In: Bennett JE, Dolin R, Blaser MJ (eds) Mandell, Douglas, and Bennett's Principles and Practice of Infectious Disease. 9th ed. Philadelphia: Elsevier Inc.; 2020. p. 285-290.

7.Murray BE, Arias CA, Nannini EC. Glycopeptides (Vancomycin and Teicoplanin) and Lipoglycopeptides (Telavancin, Oritavancin, and Dalbavancin) In: Bennett JE, Dolin R, Blaser MJ (eds) Mandell, Douglas, and Bennett's Principles and Practice of Infectious Disease. 9th ed. Philadelphia: Elsevier Inc.; 2020. p. 375-395.

Munita JM, Murray BE, Arias CA.Daptomycin and Quinupristin-Dalfopristin In: Bennett JE, Dolin R, Blaser MJ (eds) Mandell, Douglas, and Bennett's Principles and Practice of Infectious Disease. 9th ed. Philadelphia: Elsevier Inc.; 2020. p. 396-404.

Leggett JE. Aminoglycosides In: Bennett JE, Dolin R, Blaser MJ (eds) Mandell, Douglas, and Bennett's Principles and Practice of Infectious Disease. 9th ed. Philadelphia: Elsevier Inc.; 2020. p. 305-317.

Moffa M, Brook I. Tetracyclines, Glycylcyclines, and Chloramphenicol In: Bennett JE, Dolin R, Blaser MJ (eds) Mandell, Douglas, and Bennett's Principles and Practice of Infectious Disease. 9th ed. Philadelphia: Elsevier Inc.; 2020. p. 318-336.

Cox HL, Donowitz GR. Linezolid, Tedizolid, and Other Oxazolidinones In: Bennett JE, Dolin R, Blaser MJ (eds) Mandell, Douglas, and Bennett's Principles and Practice of Infectious Disease. 9th ed. Philadelphia: Elsevier Inc.; 2020. p. 410-415.

Nesbitt WJ, Aranoff DM. Macrolides and Clindamycin In: Bennett JE, Dolin R, Blaser MJ (eds) Mandell, Douglas, and Bennett's Principles and Practice of Infectious Disease. 9th ed. Philadelphia: Elsevier Inc.; 2020. p. 359-374.

Kaye KS, Pogue JM, Kaye D. Polymyxins (Polymyxin B and Colistin) In: Bennett JE, Dolin R, Blaser MJ (eds) Mandell, Douglas, and Bennett's Principles and Practice of Infectious Disease. 9th ed. Philadelphia: Elsevier Inc.; 2020. p. 405-409.

Urinary Tract Agents: Nitrofurantoin, Fosfomycin, and Methenamine In: Bennett JE, Dolin R, Blaser MJ (eds) Mandell, Douglas, and Bennett's Principles and Practice of Infectious Disease. 9th ed. Philadelphia: Elsevier Inc.; 2020. p. 461-465.

Medina E, Pieper DH. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria. Current Topics in Microbiology and Immunology 2016; 398: 3-33.

Yayınlanan

7 Mart 2025

Lisans

Lisans